Literature DB >> 16939222

WISP-2/CCN5 is involved as a novel signaling intermediate in phorbol ester-protein kinase Calpha-mediated breast tumor cell proliferation.

Krishanu Sengupta1, Snigdha Banerjee, Kakali Dhar, Neela K Saxena, Smita Mehta, Donald R Campbell, Sushanta K Banerjee.   

Abstract

PMA and active phorbol esters stimulate the proliferation of various tumor cells, including ER-positive human breast tumor cell lines. However, the specific signaling pathways involved in the PMA-induced mitogenic effect on breast tumor cells have not been fully elucidated. In the present study, we explored the mechanisms associated with the mitogenic influence of PMA on breast tumor cells. Following an acute exposure (i.e., within 2 to 6 h) to PMA (50 nM), a mitogenic effect was observed on WISP-2/CCN5-positive breast tumor cell lines, including MCF-7, ZR-75-1 and SKBR-3 cells, and induction of WISP-2/CCN5 mRNA expression paralleled the observed mitogenic proliferation. This effect was undetected in WISP-2/CCN5 negative MDA-MB-231 breast tumor cells or human mammary epithelial cells with or without ER-alpha transfection. The mitogenic effect of PMA was perturbed by short hairpin RNA (shRNA)-mediated inhibition of WISP-2/CCN5 signaling in MCF-7 cells. Moreover, the upregulation of WISP-2/CCN5 by PMA is not ER dependent but is instead mediated through a complex PKCalpha-MAPK/ERK and SAPK/JNK signaling pathway, which leads to growth stimulation of MCF-7 breast tumor cells. These series of experiments provide the first evidence that WISP-2/CCN5 is a novel signaling molecule that critically participates in the mitogenic action of PMA on noninvasive, WISP-2/CCN5-positive breast tumor cells through PKCalpha-dependent, multiple molecular signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16939222     DOI: 10.1021/bi060888p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  CCN5: biology and pathophysiology.

Authors:  Joshua W Russo; John J Castellot
Journal:  J Cell Commun Signal       Date:  2010-09-21       Impact factor: 5.782

2.  2-methoxyestradiol inhibits Barrett's esophageal adenocarcinoma growth and differentiation through differential regulation of the beta-catenin-E-cadherin axis.

Authors:  Suman Kambhampati; Snigdha Banerjee; Kakali Dhar; Smita Mehta; Inamul Haque; Gopal Dhar; Monami Majumder; Gibanananda Ray; Peter J Vanveldhuizen; Sushanta K Banerjee
Journal:  Mol Cancer Ther       Date:  2010-03-02       Impact factor: 6.261

3.  CCN5/WISP-2: A micromanager of breast cancer progression.

Authors:  Sushanta K Banerjee; Snigdha Banerjee
Journal:  J Cell Commun Signal       Date:  2012-04-10       Impact factor: 5.782

4.  Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST signaling networks in human breast cancer cells.

Authors:  Inamul Haque; Snigdha Banerjee; Smita Mehta; Archana De; Monami Majumder; Matthew S Mayo; Suman Kambhampati; Donald R Campbell; Sushanta K Banerjee
Journal:  J Biol Chem       Date:  2011-10-21       Impact factor: 5.157

5.  Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells.

Authors:  Asmaà Fritah; Cécile Saucier; Olivier De Wever; Marc Bracke; Ivan Bièche; Rosette Lidereau; Christian Gespach; Sylvain Drouot; Gérard Redeuilh; Michèle Sabbah
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

6.  WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways.

Authors:  Jiafu Ji; Shuqin Jia; Yongning Jia; Ke Ji; Rachel Hargest; Wen G Jiang
Journal:  Br J Cancer       Date:  2015-08-20       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.